HSPA9 and colonic neoplasm: UBXN2A protects the tumour suppressor function of p53 by binding mot-2 to release p53 from cellular fixation, which suggests that UBXN2A can promote cell death by interfering with the interaction of p53-mot-2 in colon cancer cells (Fig. 4D).